FDA Import Refusal AEK-0351230-6/41/1 — Janssen Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc — FEI 2242843

The FDA refused shipment AEK-0351230-6/41/1 from Janssen Pharmaceuticals, Inc (United States) on Feb 25, 2022. The refused product falls under Drugs and Biologics — RIVAROXABAN. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Feb 25, 2022
Country
United States
Product Category
Drugs and Biologics
Product Code
61LCY42 RIVAROXABAN
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.